I. A. Gillespie

High cardiovascular event rates occur within the first weeks of starting hemodialysis

F. Kronenberg, S. Anker, D. Marcelli, 2015, Kidney international.

Anti-parathyroid treatment effectiveness and persistence in incident haemodialysis patients with secondary hyperparathyroidism.

F. Kronenberg, D. Marcelli, D. Wheeler, 2016, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Development and validation of cardiovascular risk scores for haemodialysis patients.

Florian Kronenberg, Jürgen Floege, Kai-Uwe Eckardt, 2016, International journal of cardiology.

Development and validation of a predictive mortality risk score from a European hemodialysis cohort

Florian Kronenberg, Jürgen Floege, Kai-Uwe Eckardt, 2015, Kidney international.

Inflammation Modifies the Paradoxical Association between Body Mass Index and Mortality in Hemodialysis Patients.

F. Kronenberg, S. Anker, D. Marcelli, 2016, Journal of the American Society of Nephrology : JASN.

Factors precipitating erythropoiesis‐stimulating agent responsiveness in a European haemodialysis cohort: case‐crossover study†

D. Marcelli, I. Macdougall, K. Eckardt, 2015, Pharmacoepidemiology and drug safety.

Characterisation of chronic hepatitis B virus infection in the UK and risk factors for hepatocellular carcinoma: a large electronic health record-based retrospective cohort study in the QResearch primary care database.

T. Wang, C. Campbell, P. Matthews, 2022, medRxiv.

Prevalent new user designs: A literature review of current implementation practice

J. Logie, E. Williamson, I. Douglas, 2023, Pharmacoepidemiology and drug safety.